Agentix Corp. (OTCMKTS:AGTX) Stock Short Interest Report for October

Agentix Corp. (OTCMKTS:AGTX) was the target of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 9,518 shares, an increase of 52,777.8% from the October 15th total of 18 shares. Based on an average daily volume of 138,200 shares, the days-to-cover ratio is presently 0.1 days.

Agentix Stock Performance

Shares of OTCMKTS AGTX remained flat at $0.03 on Tuesday. Agentix has a 12 month low of $0.01 and a 12 month high of $0.07. The company has a fifty day moving average of $0.03 and a two-hundred day moving average of $0.03.

Agentix Company Profile

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. The company offers AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases.